Cancer cells must maintain their telomere length for their sustained proliferation, and they do so by either activating telomerase, a ribonucleoprotein complex, or by utilizing a HR-based recombination pathway, referred to as alternative lengthening of telomeres (ALT). The gene discussed is GPT; the disease is cancer.